PMID- 14592823 OWN - NLM STAT- MEDLINE DCOM- 20040420 LR - 20210206 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 103 IP - 5 DP - 2004 Mar 1 TI - Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. PG - 1602-10 AB - Among the various chemokines that are functionally active on neutrophils, platelet factor 4 (PF-4; CXCL4) appears to have a specialized role. Lacking typical chemokine activities, PF-4 stimulates neutrophils to undergo firm adhesion to endothelial cells and, in the presence of an appropriate costimulus like tumor necrosis factor (TNF), PF-4 induces exocytosis of secondary granule contents. Analyzing the individual contribution of PF-4 and its costimuli in the control of these functions at the signaling level, we demonstrate that TNF-induced activation of p38 mitogen-activated protein (MAP) kinase (but not extracellular regulated kinase [Erk] kinases) acts as general and essential costimulatory signal in PF-4-dependent neutrophil exocytosis. This was shown by the use of a specific inhibitor (SB203580), by biologic (lipopolysaccharide, N-formyl-methionyl-leucyl-phenylalanine) and pharmacologic (anisomycin) activators of p38 MAP kinase, and by phosphorylation studies. Furthermore, TNF-mediated activation of phosphatidylinositol 3-kinase (PI 3-kinase) represents an additional essential signaling component in this process as demonstrated by studies with its inhibitor wortmannin as well as by analysis of the phosphorylation of AKT kinase. PF-4, however, directly activates src-kinases and PF-4-induced adherence as well as PF-4/TNF-mediated exocytosis was inhibited by an src-kinase inhibitor PP1. Taken together, neutrophil exocytosis and adherence are regulated on p38 MAP kinase, PI 3-kinase, and src-kinase activation. FAU - Kasper, Brigitte AU - Kasper B AD - Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany. FAU - Brandt, Ernst AU - Brandt E FAU - Bulfone-Paus, Silvia AU - Bulfone-Paus S FAU - Petersen, Frank AU - Petersen F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20031030 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Enzyme Inhibitors) RN - 0 (Imidazoles) RN - 0 (Lipopolysaccharides) RN - 0 (Pyridines) RN - 37270-94-3 (Platelet Factor 4) RN - 6C74YM2NGI (Anisomycin) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.4.21.- (Lactoferrin) RN - OU13V1EYWQ (SB 203580) SB - IM MH - Anisomycin/pharmacology MH - Blotting, Western MH - Cell Adhesion MH - Cells, Cultured MH - Enzyme Activation MH - Enzyme Inhibitors/pharmacology MH - Exocytosis MH - Humans MH - Imidazoles/pharmacology MH - Lactoferrin/metabolism MH - Lipopolysaccharides/chemistry MH - Mitogen-Activated Protein Kinases/*metabolism MH - Neutrophils/*cytology/metabolism MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphorylation MH - Platelet Factor 4/metabolism/*physiology MH - Precipitin Tests MH - Pyridines/pharmacology MH - Signal Transduction MH - Time Factors MH - p38 Mitogen-Activated Protein Kinases MH - src-Family Kinases/*metabolism EDAT- 2003/11/01 05:00 MHDA- 2004/04/21 05:00 CRDT- 2003/11/01 05:00 PHST- 2003/11/01 05:00 [pubmed] PHST- 2004/04/21 05:00 [medline] PHST- 2003/11/01 05:00 [entrez] AID - S0006-4971(20)50067-0 [pii] AID - 10.1182/blood-2003-08-2802 [doi] PST - ppublish SO - Blood. 2004 Mar 1;103(5):1602-10. doi: 10.1182/blood-2003-08-2802. Epub 2003 Oct 30.